Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
39.20
+0.05 (0.13%)
Nov 20, 2024, 4:00 PM EST - Market open
Veracyte Market Cap
Veracyte has a market cap or net worth of $3.04 billion as of November 21, 2024. Its market cap has increased by 76.20% in one year.
Market Cap
3.04B
Enterprise Value
2.78B
1-Year Change
76.20%
Ranking
Category
Stock Price
$39.20
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $3.04B, an increase of 1,008.35%. That is a compound annual growth rate of 24.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 3.03B | 51.00% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xenon Pharmaceuticals | 2.90B |
| Amicus Therapeutics | 2.89B |
| HUTCHMED (China) | 2.86B |
| Verona Pharma | 2.86B |
| LivaNova | 2.85B |
| Vera Therapeutics | 2.84B |
| ACADIA Pharmaceuticals | 2.83B |
| Surgery Partners | 2.76B |